Literature DB >> 19587261

Practice-based research network studies and institutional review boards: two new issues.

Barbara P Yawn1, Deborah G Graham, Susan L Bertram, Marge J Kurland, Allen J Dietrich, Peter C Wollan, Elias C Brandt, Jessica M Huff, Wilson D Pace.   

Abstract

BACKGROUND: Practice-based research network (PBRN) study investigators must interface with multiple Institutional Review Boards (IRBs), many of which are unfamiliar with PBRN research.
OBJECTIVE: To present 2 IRB-related issues that have not appeared in the literature but occurred during the course of a large 5-year PBRN study involving 32 sites dispersed around the United States.
RESULTS: Our study required IRB approval from a total of 19 local, hospital, academic center, and professional organization-based IRBs that reviewed a protocol of postpartum depression screening and follow-up completed in English or Spanish. Initial approval of the protocol and consent forms proceeded with only the usual barriers of submitting 19 different forms, and no protocol amendments were required. However, 2 unanticipated IRB issues provided significant additional work for the study team and the local practice sites. First, several IRBs required staff to repeat human subjects training every 1 to 2 years, resulting in 92 practicing physicians, residents, and members of the nursing staff spending time completing the exact same human subjects' training at least twice during the course of this study. Second, 17 of the 19 IRBs required that the patient be given consent forms that were newly stamped and dated each year, requiring the central site to reprint and replace consent forms yearly. Because not all IRBs returned the newly stamped and dated forms in a timely fashion, study enrollment with valid consent forms was interrupted in 4 sites for periods of 2 to 13 weeks.
CONCLUSIONS: IRB requirements not directly responsive to federal regulations can add significant costs, frustrations, and burdens to PBRN studies. Non-federally mandated IRB requirements should be based on an identified need with evidence to support the solution.

Entities:  

Mesh:

Year:  2009        PMID: 19587261     DOI: 10.3122/jabfm.2009.04.080168

Source DB:  PubMed          Journal:  J Am Board Fam Med        ISSN: 1557-2625            Impact factor:   2.657


  5 in total

Review 1.  Burdens on research imposed by institutional review boards: the state of the evidence and its implications for regulatory reform.

Authors:  George Silberman; Katherine L Kahn
Journal:  Milbank Q       Date:  2011-12       Impact factor: 4.911

2.  Lessons learned in the growth and maturation stages of a community pharmacy practice-based research network: Experiences of the Medication Safety Research Network of Indiana (Rx-SafeNet).

Authors:  Mary Ann Kozak; Stephanie A Gernant; Heather M Hemmeger; Margie E Snyder
Journal:  Innov Pharm       Date:  2015

Review 3.  Research ethics education for community-engaged research: a review and research agenda.

Authors:  Emily E Anderson; Stephanie Solomon; Elizabeth Heitman; James M DuBois; Celia B Fisher; Rhonda G Kost; Mary Ellen Lawless; Cornelia Ramsey; Bonnie Jones; Alice Ammerman; Lainie Friedman Ross
Journal:  J Empir Res Hum Res Ethics       Date:  2012-04       Impact factor: 1.742

4.  Institutional review board barriers and solutions encountered in the Collaboration Among Pharmacists and Physicians to Improve Outcomes Now Study: a national multicenter practice-based implementation trial.

Authors:  Eric J Maclaughlin; Gail Ardery; Eric A Jackson; Timothy J Ives; Rodney B Young; David S Fike; Barry L Carter
Journal:  Pharmacotherapy       Date:  2013-05-03       Impact factor: 4.705

5.  Good Clinical Practice Training: Identifying Key Elements and Strategies for Increasing Training Efficiency.

Authors:  Jaime Arango; Tina Chuck; Susan S Ellenberg; Bridget Foltz; Colleen Gorman; Heidi Hinrichs; Susan McHale; Kunal Merchant; Jonathan Seltzer; Stephanie Shapley; Gretchen Wild
Journal:  Ther Innov Regul Sci       Date:  2016-03-11       Impact factor: 1.778

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.